1. Home
  2. O vs COR Comparison

O vs COR Comparison

Compare O & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • O
  • COR
  • Stock Information
  • Founded
  • O 1969
  • COR 2001
  • Country
  • O United States
  • COR United States
  • Employees
  • O N/A
  • COR N/A
  • Industry
  • O Real Estate Investment Trusts
  • COR Other Pharmaceuticals
  • Sector
  • O Real Estate
  • COR Health Care
  • Exchange
  • O Nasdaq
  • COR Nasdaq
  • Market Cap
  • O 46.0B
  • COR 44.4B
  • IPO Year
  • O N/A
  • COR N/A
  • Fundamental
  • Price
  • O $54.61
  • COR $242.06
  • Analyst Decision
  • O Hold
  • COR Buy
  • Analyst Count
  • O 15
  • COR 11
  • Target Price
  • O $62.11
  • COR $268.09
  • AVG Volume (30 Days)
  • O 5.9M
  • COR 1.2M
  • Earning Date
  • O 02-18-2025
  • COR 02-05-2025
  • Dividend Yield
  • O 5.75%
  • COR 0.91%
  • EPS Growth
  • O N/A
  • COR N/A
  • EPS
  • O 1.04
  • COR 7.53
  • Revenue
  • O $5,014,703,000.00
  • COR $293,958,599,000.00
  • Revenue This Year
  • O N/A
  • COR $9.98
  • Revenue Next Year
  • O $5.93
  • COR $6.47
  • P/E Ratio
  • O $52.28
  • COR $32.14
  • Revenue Growth
  • O 28.86
  • COR 12.12
  • 52 Week Low
  • O $50.65
  • COR $214.77
  • 52 Week High
  • O $64.88
  • COR $253.27
  • Technical
  • Relative Strength Index (RSI)
  • O 55.18
  • COR 64.12
  • Support Level
  • O $51.60
  • COR $233.61
  • Resistance Level
  • O $53.58
  • COR $241.14
  • Average True Range (ATR)
  • O 0.90
  • COR 3.94
  • MACD
  • O 0.39
  • COR 1.86
  • Stochastic Oscillator
  • O 85.88
  • COR 91.11

About O Realty Income Corporation

Realty Income owns roughly 15,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, gaming, office, manufacturing, and distribution properties, which make up roughly 20% of revenue.

About COR Cencora Inc.

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Share on Social Networks: